These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Pentraxin 3 and other inflammatory factors in central retinal vein occlusion and macular edema. Noma H; Mimura T; Masahara H; Shimada K Retina; 2014 Feb; 34(2):352-9. PubMed ID: 23842103 [TBL] [Abstract][Full Text] [Related]
17. Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K Br J Ophthalmol; 2011 Jun; 95(6):788-92. PubMed ID: 21109696 [TBL] [Abstract][Full Text] [Related]
18. Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion. Noma H; Funatsu H; Mimura T; Harino S; Sone T; Hori S Acta Ophthalmol; 2010 Sep; 88(6):646-51. PubMed ID: 19563372 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Noma H; Minamoto A; Funatsu H; Tsukamoto H; Nakano K; Yamashita H; Mishima HK Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):309-15. PubMed ID: 16133018 [TBL] [Abstract][Full Text] [Related]
20. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion. Lee WJ; Kang MH; Seong M; Cho HY Br J Ophthalmol; 2012 Nov; 96(11):1426-30. PubMed ID: 22930681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]